#skincancer treatment with viral #immunotherapy. News from #ASCO15 #dermatology #ASCO2015

Viral #immunotherapy for #skincancer shows patient benefit in Phase III trial #ASCO #JournalofClinicalOncology http://t.co/xW3Hg3M05f

— ClinicalOncologyNews (@ClinOncNews) May 26, 2015